Heparin Conjugate Pretreatment of Kidneys From Deceased Donors Before Transplantation: Results From the First-in-human Randomized Phase I Trial

Heparin Conjugate Pretreatment of Kidneys From Deceased Donors Before Transplantation: Results From the First-in-human Randomized Phase I Trial

Background. Pretreating porcine kidneys with Corline Heparin Conjugate (CHC) during hypothermic machine perfusion (HMP) has been shown to reduce preservation injury and improve early kidney function. In this first-in-human phase I study, the safety and tolerability of transplanting CHC-pretreated ki...

Full description

Bibliographic Details
Main Authors: Amir Sedigh, MD, PhD, Torbjörn Lundgren, MD, PhD, Per Lindnér, MD, PhD, Johan Nordström, MD, Peetra Magnusson, MD, PhD, Janniz Jönsson, MD, Fredrik Carlsson, MD, PhD, Rutger Ploeg, MD, PhD, Tomas Lorant, MD, PhD
Format: Article
Language:English
Published: Wolters Kluwer 2023-01-01
Series:Transplantation Direct
Online Access:http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001403

Internet

http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001403

Similar Items